BUZZ-U.S. STOCKS ON THE MOVE-Tobira, Ascena, Seaworld, DTS, Wells Fargo
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks were higher as investors saw little room for the Federal Reserve to raise interest rates in a two-day meeting starting Tuesday. The Dow Jones Industrial Average was up 0.15 percent at 18,147.59, the S&P 500 was up 0.10 percent at 2,141.26 and the Nasdaq Composite was up 0.07 percent at 5,238.6.
** TOBIRA THERAPEUTICS INC, $38.03, +702.32 pct
** ALLERGAN PLC, $238.3, -2.85 pct
Allergan said it would buy Tobira Therapeutics in a deal worth up to $1.7 billion, to gain access to experimental therapies for a fatty liver disease called NASH. Allergan's offer of $28.35 per Tobira share upfront is nearly a 500 percent premium to the stock's close on Monday.
** CONATUS PHARMACEUTICALS INC, $2.045, +16.86 pct
** INTERCEPT PHARMACEUTICALS INC, $166.58, +6.28 pct
** GALECTIN THERAPEUTICS INC, $1.9, +13.77 pct Continued...